Peter Nagy
0000-0002-0256-3304
Vadaskert Child and Adolescent Psychiatric Hospital
6 papers found
Refreshing results…
Self-Harm in Children and Adolescents Who Presented at Emergency Units During the COVID-19 Pandemic: An International Retrospective Cohort Study
Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate
EPA-0775 – Efficacy of lisdexamfetamine dimesylate and atomoxetine in child and adolescent subgroups from a head-tohead, double-blind, randomized trial in patients with attention-deficit/hyperactivity disorder
Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study
P. 7. d. 008 Efficacy of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with ADHD: head-to-head responder analyses
Replication of association between a SLITRK1 haplotype and Tourette Syndrome in a large sample of families
Missing publications? Search for publications with a matching author name.